GlassScriptPhysician profile
Lori W Couch
NPI 1265438816
$381.70
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $45.13 · 2021: $28.98 · 2022: $65.24 · 2023: $78.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $70.70 | 2019 | |
| Abbvie INC. | $60.69 | 2023 | Durysta, Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $38.32 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $36.52 | 2019-2021 | |
| Horizon Therapeutics Plc | $34.76 | 2022-2023 | Tepezza |
| Oyster Point Pharma, INC. | $22.76 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.43 | 2019 | |
| Eyevance Pharmaceuticals LLC | $17.33 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.05 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $14.59 | 2019 | |
| Sight Sciences, INC. | $13.35 | 2022 | |
| Allergan, INC. | $12.69 | 2020 | |
| Alcon Vision LLC | $12.08 | 2022 | |
| Visioneering Technologies, INC. | $8.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.